ZYCEVA 150MG (Erlotinib (150mg))

ZYCEVA 150MG TAB contains Erlotinib, which is primarily used to help manage certain types of cancer. It is commonly prescribed for patients dealing with specific forms of lung cancer and pancreatic cancer. By targeting specific proteins involved in the growth of cancer cells, ZYCEVA aims to slow down their proliferation, helping to support patients during their treatment journey.

The active ingredient, Erlotinib, works by inhibiting a receptor called the epidermal growth factor receptor (EGFR) that is often overactive in cancer cells. By blocking this receptor, it can help reduce the growth signals that these cells rely on, which may contribute to the overall management of the disease.

For best results, ZYCEVA should be stored in a cool, dry place, away from direct sunlight, and kept out of reach of children. Consistency in use is important, and patients should follow their healthcare provider’s guidance closely. It is also advisable to inform your doctor about any other medications or supplements you are taking, as interactions may occur.

Some common side effects may include mild nausea, diarrhea, or skin rash. These effects are typically manageable, but it’s important to discuss any new or worsening symptoms with a healthcare professional.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.